Press & News
We love what we do. A lot of other important folks love it too. See what they have to say about us.
Public Relations: Andrew Noble
MOUNTAIN VIEW, Calif. — Aug. 2, 2022 — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced that it was included in Fast Company’s fourth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate a steadfast commitment to encouraging innovation at all levels.
Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems
Bioinformatics company DNAnexus Inc. has raised $200 million in a ﬁnancing round led by Blackstone Inc. funds. The series I round values the Mountain View, California-based company at about $600 million, said people familiar with the matter who asked not to be identiﬁed discussing it.
Innovative Cloud-based Research Analysis Platform Launched to Increase Scale and Accessibility of Resources
UK Biobank, a large-scale biomedical database and research resource, announces today the launch of a uniquely powerful and innovative research platform that allows approved researchers to access and analyse the entire UK Biobank database securely, in the cloud, from anywhere in the world.
One or two lines of text from article goes here mollis, mauris orci dignissim nisl, id gravida nunc enim quis nibh. Maecenas convallis eros a ante dignissim, vitae elementum metus facilisis. Cras in maximus sem. Praesent libero augue, ornare eget quam sed, volutpat suscipit arcu
TwinStrand chose DNAnexus to provide the scalable and secure cloud infrastructure it needed to support customers of its DuplexSeq™ kits.
One or two lines of text from article goes here mollis, mauris orci dignissim nisl, id gravida nunc enim quis nibh. Maecenas convallis eros a ante dignissim, vitae elementum metus facilisis. Cras in maximus sem. Praesent libero augue, ornare eget quam sed, volutpat suscipit arcu.
DNAnexus Solutions are used by......
7 of the world’s top 10 pharmaceutical companies
8 of the 10 biggest diagnostics developers
Collaboration is vital to advancing scientiﬁc discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward ﬁnding cures for pediatric cancer and other life-threatening diseases.
James R. Downing, President & CEO
St. Judes Children’s Research Hospital